Clinical Trial: A Phase Ib Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain

U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07377721) titled 'A Phase Ib Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain' on Jan. 22.

Brief Summary: This study aims to investigate the efficacy and safety of HRS-2129 in Chinese diabetic peripheral neuropathic pain (DPNP) in comparison to placebo.

Study Start Date: Feb., 2026

Study Type: INTERVENTIONAL

Condition: Diabetic Peripheral Neuropathic Pain

Intervention: DRUG: HRS-2129 Tablets

HRS-2129 tablets.

DRUG: HRS-2129 Placebo

HRS-2129 placebo.

DRUG: Pregabalin Capsules

Pregabalin capsules.

DRUG: Pregabalin Capsules Placebo

Pregabalin capsules placebo

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Shandong ...